1. Home
  2. EONR vs ONVO Comparison

EONR vs ONVO Comparison

Compare EONR & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EONR
  • ONVO
  • Stock Information
  • Founded
  • EONR 2020
  • ONVO 2007
  • Country
  • EONR United States
  • ONVO United States
  • Employees
  • EONR N/A
  • ONVO N/A
  • Industry
  • EONR
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EONR
  • ONVO Health Care
  • Exchange
  • EONR NYSE
  • ONVO Nasdaq
  • Market Cap
  • EONR 6.1M
  • ONVO 6.9M
  • IPO Year
  • EONR N/A
  • ONVO N/A
  • Fundamental
  • Price
  • EONR $1.33
  • ONVO $0.46
  • Analyst Decision
  • EONR
  • ONVO
  • Analyst Count
  • EONR 0
  • ONVO 0
  • Target Price
  • EONR N/A
  • ONVO N/A
  • AVG Volume (30 Days)
  • EONR 5.1M
  • ONVO 68.6K
  • Earning Date
  • EONR 11-15-2024
  • ONVO 11-07-2024
  • Dividend Yield
  • EONR N/A
  • ONVO N/A
  • EPS Growth
  • EONR N/A
  • ONVO N/A
  • EPS
  • EONR N/A
  • ONVO N/A
  • Revenue
  • EONR $22,964,891.00
  • ONVO $73,000.00
  • Revenue This Year
  • EONR N/A
  • ONVO $59.08
  • Revenue Next Year
  • EONR N/A
  • ONVO $18.24
  • P/E Ratio
  • EONR N/A
  • ONVO N/A
  • Revenue Growth
  • EONR N/A
  • ONVO N/A
  • 52 Week Low
  • EONR $0.81
  • ONVO $0.43
  • 52 Week High
  • EONR $13.93
  • ONVO $2.05
  • Technical
  • Relative Strength Index (RSI)
  • EONR N/A
  • ONVO 44.79
  • Support Level
  • EONR N/A
  • ONVO $0.44
  • Resistance Level
  • EONR N/A
  • ONVO $0.48
  • Average True Range (ATR)
  • EONR 0.00
  • ONVO 0.03
  • MACD
  • EONR 0.00
  • ONVO 0.00
  • Stochastic Oscillator
  • EONR 0.00
  • ONVO 26.09

About EONR EON RESOURCES INC

HNR Acquisition Corp is a blank check company.

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Share on Social Networks: